Latest Genomic Valley Biotech stock price
Genomic Valley Biotech P/E Ratio
GVBL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
24.1
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
24.1
Current Price
₹28.20
EPS (TTM)
₹1.17
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.09
Sector Median
27.37
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Genomic Valley Biotech
- Trading at discount to sector average PE of 48.09
View the GVBL equity price for detailed stock performance.
Related Pages for Genomic Valley Biotech
Additional stock information and data for GVBL
Sector P/E Ratio Comparison
Comparing Genomic Valley Biotech with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |